Subscribe to RSS
DOI: 10.1055/a-2737-6482
Comparing Blood Loss in Immediate and Delayed Autologous Breast Reconstruction
Authors
Abstract
Background
Blood loss is a critical component of all surgical procedures. Excess blood loss may require a blood transfusion and increase the risk of complications after autologous breast reconstruction.
Methods
Retrospective cohort of 264 consecutive autologous breast reconstruction patients between July 2017 and June 2022. Patients were stratified by reconstruction timing and bilateral versus unilateral reconstruction. Postoperative hemoglobin reduction and transfusion incidence were the primary outcomes of interest.
Results
Average preoperative hemoglobin (12.6 g/dL) was equivalent among all groups. Comparing bilateral immediate (n = 77) and delayed (n = 50) patients, immediate reconstructions had greater postoperative hemoglobin losses (−3.26 g/dL vs. −1.98 g/dL, p < 0.01) and higher transfusion rates (14% vs. 2.0%, p = 0.02). Comparing unilateral immediate (n = 99) and delayed (n = 38) patients, immediate reconstructions had greater hemoglobin losses (−2.60 g/dL vs. −1.41 g/dL, p < 0.0001) and higher transfusion rates (12.1% vs. 0.0%, p = 0.03). Using regression analysis, controlling for confounding variables and intraoperative resuscitation risk factors for blood transfusion requirement, were postmastectomy radiation therapy requirement (odds ratio [OR]: 10.3, p < 0.01) and vascular disease (OR: 14.5, p = 0.02). Unilateral reconstruction was protective from requiring transfusion (OR: 0.20, p = 0.03). Increasing BMI was protective, and with each increasing unit of BMI, transfusion requirement incidence decreased by 12.3% (p = 0.04). Transfusion was not associated with flap thrombosis or flap loss.
Conclusion
Compared to immediate autologous breast reconstruction, a staged approach to both unilateral and bilateral patients can help minimize the risk of transfusion requirement. These factors, as well as additional modifiable and nonmodifiable risk factors, should be considered when determining the timing of autologous breast reconstruction for a patient.
Note
This work was presented at the Virginia Society of Plastic Surgeons Meeting 2023, held at VCU Medical Center, Richmond, Virginia, United States, on October 16, 2023, and at Plastic Surgery The Meeting 2024, held in San Diego, California, United States, from September 26 to 29, 2024.
Publication History
Received: 20 April 2025
Accepted: 03 November 2025
Accepted Manuscript online:
06 November 2025
Article published online:
19 November 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA. Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstr Aesthet Surg 2020; 73 (02) 278-285
- 2 Rozen WM, Ashton MW. Improving outcomes in autologous breast reconstruction. Aesthetic Plast Surg 2009; 33 (03) 327-335
- 3 Yueh JH, Slavin SA, Adesiyun T. et al. Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg 2010; 125 (06) 1585-1595
- 4 Atisha DM, Alderman AK, Kuhn LE, Wilkins EG. The impact of obesity on patient satisfaction with breast reconstruction. Plast Reconstr Surg 2008; 121 (06) 1893-1899
- 5 Garza III R, Ochoa O, Chrysopoulo M. Post-mastectomy breast reconstruction with autologous tissue: current methods and techniques. Plast Reconstr Surg Glob Open 2021; 9 (02) e3433
- 6 Sisk GC, Chao AH. Advances in autologous breast reconstruction. Curr Surg Rep 2021; 9: 1-9
- 7 Kaidar-Person O, Hermann N, Poortmans P. et al. A multidisciplinary approach for autologous breast reconstruction: a narrative (re)view for better management. Radiother Oncol 2021; 157: 263-271
- 8 Rinker BD, Bowling JT, Vasconez HC. Blood transfusion and risk of metastatic disease or recurrence in patients undergoing immediate TRAM flap breast reconstruction: a clinical study and meta-analysis. Plast Reconstr Surg 2007; 119 (07) 2001-2007
- 9 Savage WJ. Transfusion reactions. Hematol Oncol Clin North Am 2016; 30 (03) 619-634
- 10 Masoomi H, Blumenauer BJ, Blakkolb CL, Marques ES, Greives MR. Predictors of blood transfusion in autologous breast reconstruction surgery: a retrospective study using the Nationwide Inpatient Sample database. J Plast Reconstr Aesthet Surg 2019; 72 (10) 1616-1622
- 11 Fischer JP, Nelson JA, Sieber B. et al. Transfusions in autologous breast reconstructions: an analysis of risk factors, complications, and cost. Ann Plast Surg 2014; 72 (05) 566-571
- 12 Appleton SE, Ngan A, Kent B, Morris SF. Risk factors influencing transfusion rates in DIEP flap breast reconstruction. Plast Reconstr Surg 2011; 127 (05) 1773-1782
- 13 Malekpour M, Malekpour F, Wang HT. Breast reconstruction: review of current autologous and implant-based techniques and long-term oncologic outcome. World J Clin Cases 2023; 11 (10) 2201-2212
- 14 Lymperopoulos NS, Sofos S, Constantinides J, Koshy O, Graham K. Blood loss and transfusion rates in DIEP flap breast reconstruction. Introducing a new predictor. J Plast Reconstr Aesthet Surg 2013; 66 (12) 1659-1664
- 15 “CPT Code 19364 - Repair and/or Reconstruction Procedures on the Breast - Codify by AAPC.”. CPT Code 19364 - Repair and/or Reconstruction Procedures on the Breast - Codify by AAPC. Accessed March 25, 2025 at: www.aapc.com/codes/cpt-codes/19364?srsltid=AfmBOorWJgdvAEX-Et18KnO19nCgYlYQ-VQN-aw1hb6LoJZlAeZNXNvt
- 16 Sanchez-Porro Gil L, Leon Vintro X, Lopez Fernandez S. et al. The effect of perioperative blood transfusions on microvascular anastomoses. J Clin Med 2021; 10 (06) 1333
- 17 Karamanos E, Shah AR, Kim JN, Wang HT. Impact of blood transfusion in free flap breast reconstruction using propensity score matching. J Reconstr Microsurg 2021; 37 (04) 315-321
- 18 Orr JP, Shammas RL, Thomas AB. et al. Bleeding after free flap-based breast reconstruction: a NSQIP analysis. J Reconstr Microsurg 2019; 35 (06) 417-424
- 19 Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006; 2006 (01) CD005033
- 20 Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013; 110 (05) 690-701
- 21 Xu J, Bai J, Pan H, Zhou Z. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: a meta-analysis and systematic review. Medicine (Baltimore) 2024; 103 (14) e37646
- 22 Pysz M. Blood transfusions in breast cancer patients undergoing mastectomy: possible importance of timing. J Surg Oncol 2000; 75 (04) 258
- 23 Herman K, Kołodziejski L. Blood transfusion and survival after surgery for stage I and II breast cancer. Neoplasma 1993; 40 (02) 117-125
- 24 Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses Jr AH. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 1985; 97 (02) 225-230
- 25 Eickhoff JH, Andersen PM, Nørgård H. Effect of perioperative blood transfusion on recurrence and death after mastectomy for breast cancer. Acta Chir Scand 1988; 154 (7–8): 425-428
- 26 Eickhoff JH, Andersen J, Laybourn C. The Danish Breast Cancer Cooperative Group. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. Br J Surg 1991; 78 (11) 1358-1361
- 27 Sharma D, Kaur R, Sood T. et al. Incidence and risk factors of acute transfusion reactions in patients admitted in intensive care unit on active monitoring after transfusion. Transfus Clin Biol 2025; 32 (02) 147-152
- 28 Wang M, Chen M, Ao H, Chen S, Wang Z. The effects of different BMI on blood loss and transfusions in Chinese patients undergoing coronary artery bypass grafting. Ann Thorac Cardiovasc Surg 2017; 23 (02) 83-90
- 29 Erben HC, Hess F, Welter J. et al. Perioperative blood transfusions in hip and knee arthroplasty: a retrospective assessment of combined risk factors. Arch Orthop Trauma Surg 2022; 142 (08) 1817-1822
- 30 O'Brien D, Pekcan A, Stanton E. et al. The impact of perioperative blood transfusion on flap survival: a single-center review of limb salvage in the trauma setting. J Reconstr Microsurg 2025; 41 (07) 614-622
- 31 Swiekatowski KR, Manisundaram AD, Woods DE, Green JC, Bhadkamkar MA, Wu-Fienberg Y. The hidden risks of perioperative transfusions in traumatic lower extremity free flap reconstruction. J Reconstr Microsurg 2024; 40 (08) 627-634
- 32 Stranix JT, Lee ZH, Jacoby A. et al. Not all Gustilo type IIIB fractures are created equal: arterial injury impacts limb salvage outcomes. Plast Reconstr Surg 2017; 140 (05) 1033-1041
- 33 Yoon AP, Qi J, Brown DL. et al. Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast 2018; 37: 72-79
- 34 Bae J, Lee DDU, Lee KT, Pyon JK, Jeon BJ, Mun GH. The early postoperative effects of rinsing the breast pocket with tranexamic acid in prepectoral prosthetic breast reconstruction. J Plast Reconstr Aesthet Surg 2024; 89: 125-133
- 35 Safran T, Vorstenbosch J, Viezel-Mathieu A, Davison P, Dionisopoulos T. Topical tranexamic acid in breast reconstruction: a double-blind randomized controlled trial. Plast Reconstr Surg 2023; 152 (04) 699-706
- 36 Ausen K, Hagen AI, Østbyhaug HS. et al. Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial. BJS Open 2020; 4 (02) 216-224
- 37 Nichols G, Andrade E, Gregoski M, Herrera FA, Armstrong MB. Local infiltration of tranexamic acid in breast reduction for symptomatic macromastia. Ann Plast Surg 2023; 90 (6S, suppl 4): S366-S370
- 38 Parmeshwar N, Mehta SR, Piper M. Reviewing the impact of topical and intravenous tranexamic acid use in breast plastic surgery. Ann Plast Surg 2023; 91 (05) 622-628
- 39 Weissler JM, Kuruoglu D, Antezana L. et al. Efficacy of tranexamic acid in reducing seroma and hematoma formation following reduction mammaplasty. Aesthet Surg J 2022; 42 (06) 616-625
- 40 Lonie S, Abesamis GM, Law J. et al. Topical tranexamic acid in primary breast augmentation surgery: short- and long-term outcomes. Aesthet Surg J 2023; 44 (01) NP23-NP27
